Treatment was initiated with neoadjuvant imatinib 600 mg daily for 5 months
The primary tumor was stable during this time, the liver mass size decreased from 7 cm to 4 cm
The patient was referred to a surgeon and underwent hepatectomy for the liver metastasis
Following surgery, R0 resection with clear margins
Treatment was initiated with imatinib 800 mg daily
August 2016
Abdominal CT imaging findings:
Multiple peritoneal implants
A new small nodule (<1 cm) in the liver
The patient could perform all activities independently with small occasional breaks, but could not perform physically strenuous activities
He was switched to sunitinib 37.5 mg daily
February 2017
At his 6-month follow-up, the patient was still able to perform most non-strenuous activities independently; however, the frequency of being able to do so had declined significantly
Abdominal CT scan showed progression in multiple peritoneal implants; the liver nodule increased in size to 2 cm
He was referred to an academic center
His treatment was switched to regorafenib 160 mg, 3 weeks on, 1 week off
The patient appeared to tolerate therapy well, after initial dose modification due to diarrhea experienced during the second week of therapy
At the 6-month follow-up:
Abdominal CT scan showed slight reduction in the peritoneal implants